公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2020 | Landscape of mitochondria genome and clinical outcomes in stage 1 lung adenocarcinoma | Raghav L.; Chang Y.-H.; Hsu Y.-C.; Li Y.-C.; Chen C.-Y.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Chuang C.-Y.; Lee M.-H.; Wang C.-L.; HUEI-WEN CHEN ; SUNG-LIANG YU ; SHENG-FANG SU ; Yuan S.-S.; Chen J.J.W.; Ho S.-Y.; Li K.-C.; PAN-CHYR YANG ; Chang G.-C.; Chen H.-Y. | Cancers | 8 | 8 | |
2021 | The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer | Wu M.-F.; Lin C.-A.; Yuan T.-H.; Yeh H.-Y.; SHENG-FANG SU ; Guo C.-L.; Chang G.-C.; Li K.-C.; CHAO-CHI HO ; HUEI-WEN CHEN | Cancer Immunology, Immunotherapy | 23 | 23 | |
2017 | Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage likely involving its own activity | Tseng C.-C.; Jia B.; Barndt R.; Gu Y.; Chen C.-Y.; Tseng I.-C.; SHENG-FANG SU ; Wang J.-K.; Johnson M.D.; Lin C.-Y. | PLoS ONE | 27 | 26 | |
2013 | MiR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer | SHENG-FANG SU ; Chang Y.-W.; Andreu-Vieyra C.; Fang J.Y.; Yang Z.; Han B.; Lee A.S.; Liang G. | Oncogene | 103 | 98 | |
2014 | A panel of three markers hyper- And hypomethylated in urine sediments accurately predicts bladder cancer recurrence | SHENG-FANG SU ; De Castro Abreu A.L.; Chihara Y.; Tsai Y.; Andreu-Vieyra C.; Daneshmand S.; Skinner E.C.; Jones P.A.; Siegmund K.D.; Liang G. | Clinical Cancer Research | 71 | 66 | |
2008 | Purification from human milk of matriptase complexes with secreted serpins: Mechanism for inhibition of matriptase other than HAI-1 | Tseng I.-C.; Chou F.-P.; SHENG-FANG SU ; Oberst M.; Madayiputhiya N.; MING-SHYUE LEE ; Wang J.-K.; Sloane D.E.; Johnson M.; Lin C.-Y. | American Journal of Physiology - Cell Physiology | 39 | 36 | |
2014 | Reprogramming of the human intestinal epigenome by surgical tissue transposition | Lay F.D.; Triche Jr. T.J.; Tsai Y.C.; SHENG-FANG SU ; Martin S.E.; Daneshmand S.; Skinner E.C.; Liang G.; Chihara Y.; Jones P.A. | Genome Research | 14 | 14 | |
2023 | Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling | YU-CHIEH TSAI ; Wang, Tzu-Yin; Hsu, Chia-Lang; WEI-CHOU LIN ; Chen, Jyun-Yu; Li, Jia-Hua; YEONG-SHIAU PU ; ANN-LII CHENG ; CHIA-HSIEN CHENG ; SHENG-FANG SU | British journal of cancer | 4 | 4 | |
2006 | Titanium dioxide nanoparticles induce emphysema-like lung injury in mice | HUEI-WEN CHEN ; SHENG-FANG SU ; Chien C.-T.; Lin W.-H.; SUNG-LIANG YU ; Chou C.-C.; Chen J.J.W.; PAN-CHYR YANG | FASEB Journal | 302 | 234 | |
2022 | Tumor Immune Microenvironment of Soft Tissue Sarcoma | WEI-WU CHEN ; SHENG-FANG SU ; Tseng, William W. | Cancer Metastasis Through the Lymphovascular System | 1 | 0 | |
2021 | Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts | Lee P.-J.; CHAO-CHI HO ; Ho H.; Chen W.-J.; Lin C.-H.; Lai Y.-H.; Juan Y.-C.; Chu W.-C.; Lee J.-H.; SHENG-FANG SU ; Chen H.-Y.; Chen J.J.W.; Chang G.-C.; Li K.-C.; PAN-CHYR YANG ; HUEI-WEN CHEN | Theranostics | 10 | 10 | |
2008 | Zymogen activation, inhibition, and ectodomain shedding of matriptase | Lin C.-Y.; Tseng I.-C.; Chou F.-P.; SHENG-FANG SU ; Chen Y.-W.; Johnson M.D.; Dickson R.B. | Frontiers in Bioscience | 67 | 67 |